-
Loading metrics
Open Access
Peer-reviewed
Research Article
Placenta-Enriched LincRNAs MIR503HG and LINC00629 Decrease Migration and Invasion Potential of JEG-3 Cell Line
-
Bruna Rodrigues Muys,
Affiliations Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil, Center for Cell-Based Therapy (CEPID/FAPESP), National institute of Science and Technology in Stem Cell and Cell Therapy (INCTC/CNPq), Regional Blood Center of Ribeirão Preto, Riberão Preto, Brazil, Center for Medical Genomics (HCFMRP/USP), Center for Integrative Systems Biology (CISBi–NAP/USP), Ribeirão Preto, Brazil
⨯ -
Júlio Cesar Cetrulo Lorenzi,
Affiliations Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil, Center for Cell-Based Therapy (CEPID/FAPESP), National institute of Science and Technology in Stem Cell and Cell Therapy (INCTC/CNPq), Regional Blood Center of Ribeirão Preto, Riberão Preto, Brazil, Center for Medical Genomics (HCFMRP/USP), Center for Integrative Systems Biology (CISBi–NAP/USP), Ribeirão Preto, Brazil
⨯ -
Dalila Luciola Zanette,
Affiliation Gonçalo Moniz Research Center, Oswaldo Cruz Foundation, Bahia, Brazil
⨯ -
Rafaela de Barros Lima e Bueno,
Affiliations Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil, Center for Cell-Based Therapy (CEPID/FAPESP), National institute of Science and Technology in Stem Cell and Cell Therapy (INCTC/CNPq), Regional Blood Center of Ribeirão Preto, Riberão Preto, Brazil, Center for Medical Genomics (HCFMRP/USP), Center for Integrative Systems Biology (CISBi–NAP/USP), Ribeirão Preto, Brazil
⨯ -
Luíza Ferreira de Araújo,
Affiliations Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil, Center for Cell-Based Therapy (CEPID/FAPESP), National institute of Science and Technology in Stem Cell and Cell Therapy (INCTC/CNPq), Regional Blood Center of Ribeirão Preto, Riberão Preto, Brazil, Center for Medical Genomics (HCFMRP/USP), Center for Integrative Systems Biology (CISBi–NAP/USP), Ribeirão Preto, Brazil
⨯ -
Anemari Ramos Dinarte-Santos,
Affiliations Center for Cell-Based Therapy (CEPID/FAPESP), National institute of Science and Technology in Stem Cell and Cell Therapy (INCTC/CNPq), Regional Blood Center of Ribeirão Preto, Riberão Preto, Brazil, Center for Medical Genomics (HCFMRP/USP), Center for Integrative Systems Biology (CISBi–NAP/USP), Ribeirão Preto, Brazil
⨯ -
Cleidson Pádua Alves,
Affiliations Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil, Center for Cell-Based Therapy (CEPID/FAPESP), National institute of Science and Technology in Stem Cell and Cell Therapy (INCTC/CNPq), Regional Blood Center of Ribeirão Preto, Riberão Preto, Brazil, Center for Medical Genomics (HCFMRP/USP), Center for Integrative Systems Biology (CISBi–NAP/USP), Ribeirão Preto, Brazil
⨯ -
Anelisa Ramão,
Affiliations Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil, Center for Cell-Based Therapy (CEPID/FAPESP), National institute of Science and Technology in Stem Cell and Cell Therapy (INCTC/CNPq), Regional Blood Center of Ribeirão Preto, Riberão Preto, Brazil
⨯ -
Greice Andreotti de Molfetta,
Affiliations Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil, Center for Cell-Based Therapy (CEPID/FAPESP), National institute of Science and Technology in Stem Cell and Cell Therapy (INCTC/CNPq), Regional Blood Center of Ribeirão Preto, Riberão Preto, Brazil, Center for Medical Genomics (HCFMRP/USP), Center for Integrative Systems Biology (CISBi–NAP/USP), Ribeirão Preto, Brazil
⨯ -
Daniel Onofre Vidal,
Affiliation Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil
⨯ -
Wilson Araújo Silva Jr.
* E-mail: wilsonjr@usp.br
Affiliations Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil, Center for Cell-Based Therapy (CEPID/FAPESP), National institute of Science and Technology in Stem Cell and Cell Therapy (INCTC/CNPq), Regional Blood Center of Ribeirão Preto, Riberão Preto, Brazil, Center for Medical Genomics (HCFMRP/USP), Center for Integrative Systems Biology (CISBi–NAP/USP), Ribeirão Preto, Brazil
⨯
Placenta-Enriched LincRNAs MIR503HG and LINC00629 Decrease Migration and Invasion Potential of JEG-3 Cell Line
- Bruna Rodrigues Muys,
- Júlio Cesar Cetrulo Lorenzi,
- Dalila Luciola Zanette,
- Rafaela de Barros Lima e Bueno,
- Luíza Ferreira de Araújo,
- Anemari Ramos Dinarte-Santos,
- Cleidson Pádua Alves,
- Anelisa Ramão,
- Greice Andreotti de Molfetta,
- Daniel Onofre Vidal
- Published: March 29, 2016
- https://doi.org/10.1371/journal.pone.0151560